2022 - Cardiosafety Testing Based on CiPA - at Scale with SyncroPatch 384 and Genedata Screener

 icon sp96  SyncroPatch 384 poster, SLAS 2022  logo pdf   (1.3 MB)

Abstract:

The direct interaction between the SyncroPatch 384 instrument and Genedata Screener enables seamless, rigorous analysis of hERG, Nav1.5, and other CiPA-mandated ion channel assays in an automated workflow. It makes it easier to consistently apply CiPA guidelines to large-scale, early discovery screens and incorporate them as part of standard operating procedure, including full data traceability and reporting.


Back to Overview

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.